Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Targeting Hypoxia-Inducible Factor (HIF-1) in Cancer: Cutting Gordian Knot of Cancer Cell Metabolism
Abhilasha Sharma, Sonam Sinha, Neeta Shrivastava
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Revisited Metabolic Control and Reprogramming Cancers by Means of the Warburg Effect in Tumor Cells
Fukushi Abekura, Hee-Do Kim, Yu‐Chan Chang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10037-10037
Open Access | Times Cited: 95
Hallmarks of cancer resistance
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 14
CRABP2 affects chemotherapy resistance of ovarian cancer by regulating the expression of HIF1α
Xin Fu, Qian Zhang, Zhaosong Wang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Regulation of the HIF switch in human endothelial and cancer cells
Jakub Sławski, Maciej Jaśkiewicz, Anna Barton, et al.
European Journal of Cell Biology (2024) Vol. 103, Iss. 2, pp. 151386-151386
Open Access | Times Cited: 9
Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment
Adnan Moinuddin, Sophie M. Poznanski, Ana L. Portillo, et al.
Immunological Reviews (2024) Vol. 323, Iss. 1, pp. 19-39
Closed Access | Times Cited: 7
Deregulated transcription factors in cancer cell metabolisms and reprogramming
Rajni Kant, Rajesh Manne, Mohammad Anas, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 1158-1174
Open Access | Times Cited: 29
Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens
Nityanand Srivastava, Salman Sadullah Usmani, Rajasekaran Subbarayan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 20
Systematic and comprehensive insights into HIF-1 stabilization under normoxic conditions: implications for cellular adaptation and therapeutic strategies in cancer
Jiayi Zhang, Mengqin Yao, Siyu Xia, et al.
Cellular & Molecular Biology Letters (2025) Vol. 30, Iss. 1
Open Access
m6A methyltransferase KIAA1429 accelerates oral squamous cell carcinoma via regulating glycolysis and ferroptosis
Xu Ke, Xiaojuan Dai, Jincheng Yue
Translational Oncology (2023) Vol. 36, pp. 101745-101745
Open Access | Times Cited: 12
Preclinical evidence using synthetic compounds and natural products indicates that AMPK represents a potential pharmacological target for the therapy of pulmonary diseases
Chao Yang, Limor Rubin, Xiyong Yu, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 3, pp. 1326-1369
Closed Access | Times Cited: 4
Marine-Derived Leads as Anticancer Candidates by Disrupting Hypoxic Signaling through Hypoxia-Inducible Factors Inhibition
María Rita Concepción García, Paula B. Andrade, Florence Lefranc, et al.
Marine Drugs (2024) Vol. 22, Iss. 4, pp. 143-143
Open Access | Times Cited: 4
Crosstalk between hypoxia-induced pyroptosis and immune escape in cancer: From mechanisms to therapy
Seyed Mohammadmahdi Meybodi, Mahsa Ejlalidiz, Mohammadsadegh Rezaeian Manshadi, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 197, pp. 104340-104340
Open Access | Times Cited: 4
Acute vs. chronic vs. intermittent hypoxia in breast Cancer: a review on its application in in vitro research
Qiuyu Liu, Victoria A. C. Palmgren, Erik H.J. Danen, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 11, pp. 10961-10973
Open Access | Times Cited: 20
Biological function, regulatory mechanism, and clinical application of mannose in cancer
Haoyi Jin, Xi Liu, Hongxu Liu
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188970-188970
Closed Access | Times Cited: 10
HIF-1 mediated metabolic reprogramming in cancer: Mechanisms and therapeutic implications
Nikita Taneja, Akansha Chauhan, Ritu Kulshreshtha, et al.
Life Sciences (2024) Vol. 352, pp. 122890-122890
Closed Access | Times Cited: 3
Photodynamic Therapy Review: Past, Present, Future, Opportunities and Challenges
Yaran Allamyradov, Justice ben Yosef, Berdimyrat Annamuradov, et al.
Photochem (2024) Vol. 4, Iss. 4, pp. 434-461
Open Access | Times Cited: 3
Macrophage-Derived Extracellular Vesicles: A Promising Tool for Personalized Cancer Therapy
Antonella Barone, Nicola d’Avanzo, Maria Chiara Cristiano, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1252-1252
Open Access | Times Cited: 17
Transcriptome Analysis Reveals Anti-Cancer Effects of Isorhapontigenin (ISO) on Highly Invasive Human T24 Bladder Cancer Cells
Alex H. Li, Sun Young Park, Peiwei Li, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1783-1783
Open Access | Times Cited: 2
Optimizing therapeutic targets for breast cancer using boolean network models
Domenico Sgariglia, Flávia Raquel Gonçalves Carneiro, Luis Alfredo Vidal de Carvalho, et al.
Computational Biology and Chemistry (2024) Vol. 109, pp. 108022-108022
Open Access | Times Cited: 2
Metabolic Reprogramming in Thyroid Cancer
Sang Hyeon Ju, Minchul Song, Joung Youl Lim, et al.
Endocrinology and Metabolism (2024) Vol. 39, Iss. 3, pp. 425-444
Open Access | Times Cited: 2
The role of PI3K-Akt-mTOR axis in Warburg effect and its modification by specific protein kinase inhibitors in human and rat inflammatory macrophages
Gábor Bőgel, Gergely Sváb, József Murányi, et al.
International Immunopharmacology (2024) Vol. 141, pp. 112957-112957
Open Access | Times Cited: 2
Programmable Nanomodulators for Precision Therapy, Engineering Tumor Metabolism to Enhance Therapeutic Efficacy
Siwei Liu, Zhijun Liu, Huajiang Lei, et al.
Advanced Healthcare Materials (2024) Vol. 14, Iss. 4
Closed Access | Times Cited: 2
Focusing on the Role of Natural Products in Overcoming Cancer Drug Resistance: An Autophagy-Based Perspective
Jiaqi Yao, Chi Ma, Kaixuan Feng, et al.
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1565-1565
Open Access | Times Cited: 11
Research progress of potential factors influencing photodynamic therapy for gastrointestinal cancer
Puyi He, Fan Zhang, Bo Xu, et al.
Photodiagnosis and Photodynamic Therapy (2023) Vol. 41, pp. 103271-103271
Closed Access | Times Cited: 6
MUC1 aptamer-conjugated niclosamide-loaded PLGA-PEG nanoparticles attenuate HIF-1 stabilization upon hypoxia in MCF7 breast cancer cells
Morteza Eskandani, Ariya Mohabbat, Alireza Karimiyan, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 92, pp. 105278-105278
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top